Identifying novel SMYD3 interactors on the trail of cancer hallmarks.
Comput Struct Biotechnol J
; 20: 1860-1875, 2022.
Article
en En
| MEDLINE
| ID: mdl-35495117
AMPK, 5'AMP-activated protein kinase; BLM, Bloom syndrome protein; CRC, colorectal cancer; EMT, epithelial-mesenchymal transition; GC, gastric cancer; Gastrointestinal cancer cell lines; H3K4, histone H3 lysine 4; H4K5, histone H4 lysine 5; HCC, hepatocellular carcinoma; HGF, hepatocyte growth factor; Hallmarks of cancer; In silico tripeptide screening; PC, pancreatic cancer; PPIs, proteinprotein interactions; RB, retinoblastoma protein; SMYD3; SMYD3 interactome; SMYD3i, SMYD3 inhibitor; UCEC, uterine corpus endometrial carcinoma
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Comput Struct Biotechnol J
Año:
2022
Tipo del documento:
Article
País de afiliación:
Italia